TrialHaematologica2025

Dynamic change in Epstein-Barr virus DNA predicts prognosis in early stage natural killer/T-cell lymphoma with pegaspargase-based treatment: long-term follow-up and biomarker analysis from the NHL-004 multicenter randomized study.

Huijuan Zhong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.